Pathogenetic mechanisms and therapeutical approaches in infections with the HB virus.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D015119:Aminocaproic Acid / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D045930:Anabolic Agents; D007978:Levamisole; D006493:Heparin; D002991:Clofazimine; D014805:Vitamin B 12; D015119:Aminocaproic Acid